RE

Regeneron Pharmaceuticals IncNASDAQ REGN Stock Report

Last reporting period 30 Jun, 2024

Updated 19 Sep, 2024

Last price

Market cap $B

124.33

Mega

Exchange

XNAS - Nasdaq

View Section: Dividends

REGN Profile, Market Tickers and Other

RE

Insights related to Regeneron


Healthcare Stocks Review
Healthcare Stocks Review

Why should we even talk about investing in healthcare companies? The healthcare sector is traditionally considered a safe haven. During periods of slowdown and recession, it is considered profitable to invest in shares of this sector. Let’s figure out how relevant this is today and whether VEEV stock or REGN stock can save our brokerage […]


Exploring Stock Beta and Profiting from Low Beta Stocks
Exploring Stock Beta and Profiting from Low Beta Stocks

Introduction: Let’s start by introducing the concept of the Beta coefficient (β) for a stock and its importance in investment analysis. Beta is a measure of the volatility of a specific stock compared to the overall market. Investors often use the Beta coefficient (β) to assess the risk and potential returns, both for individual stocks […]

See collections related to Regeneron Pharmaceuticals Inc

REGN profile

  • Ticker

    REGN

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    02 April 1991

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    11851

  • City

    Tarrytown

  • Address

    777 Old Saw Mill River Road

  • Cusip

    75886F107

View Section: FAQ